Clinical and immunopathologic features of idiopathic cutaneous immunoglobulin M/G vasculitis versus idiopathic skin-limited immunoglobulin A vasculitis

J Am Acad Dermatol. 2021 Jan;84(1):175-178. doi: 10.1016/j.jaad.2020.04.060. Epub 2020 Apr 22.
No abstract available

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Dermatologic Agents / therapeutic use
  • Female
  • Humans
  • Immunoglobulin G*
  • Immunoglobulin M*
  • Male
  • Middle Aged
  • Recurrence
  • Remission Induction
  • Retrospective Studies
  • Treatment Outcome
  • Vasculitis, Leukocytoclastic, Cutaneous / drug therapy
  • Vasculitis, Leukocytoclastic, Cutaneous / immunology*
  • Vasculitis, Leukocytoclastic, Cutaneous / pathology*

Substances

  • Adrenal Cortex Hormones
  • Dermatologic Agents
  • Immunoglobulin G
  • Immunoglobulin M